Abstract
Actinobacteria are gram-positive filamentous bacteria which contains some of the most deadly human pathogens (Mycobacterium tuberculosis, M. leprae, Corynebacterium diphtheriae, Nocardia farcinica), plant pathogens (Streptomyces scabies, Leifsonia xyli) along with organisms that produces antibiotic (Streptomycetes, Amycolatopsis, Salinospora). Interestingly, these bacteria are equipped with an extraordinary capability of producing antibiotics and other metabolites which have medicinal properties. With the advent of inexpensive genome sequencing techniques and their clinical importance, many genomes of Actinobacteria have been successfully sequenced. These days, with the constant increasing number of drug-resistant bacteria, the urgent need for discovering new antibiotics has emerged as a major scientific challenge. And, unfortunately the traditional method of screening bacterial strains for the production of antibiotics has decreased leading to a paradigm shift in the planning and execution of discovery of novel biosynthetic gene clusters via genome mining process. The entire focus has shifted to the evaluation of genetic capacity of organisms for metabolite production and activation of cryptic gene clusters. This has been made possible only due to the availability of genome sequencing and has been augmented by genomic studies and new biotechnological approaches. Through this article, we present the analysis of the genomes of species belonging to the genus Amycolatopsis, sequenced till date with a focus on completely sequenced genomes and their application for further studies.
Similar content being viewed by others
References
Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, Chater KF, van Sinderen D (2007) Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev 71:495–548. doi:10.1128/MMBR.00005-07
Frasch HJ, Kalan L, Kilian R, Martin T, Wright GD, Stegmann E (2015) Alternative pathway to a glycopeptide-resistant cell wall in the balhimycin producer Amycolatopsis balhimycina. ACS Infect Dis 1:243–252. doi:10.1021/acsinfecdis.5b00011
Xu L, Huang H, Wei W, Zhong Y, Tang B, Yuan H, Zhu L, Huang W, Ge M, Yang S, Zheng H, Jiang W, Chen D, Zhao GP, Zhao W (2014) Complete genome sequence and comparative analyses of the vancomycin-producing Amycolatopsis orientalis. BMC Genom 15:363. doi:10.1186/1471-2164-15-363
Nigam A, Almabruk KH, Saxena A, Yang J, Mukherjee U, Kaur H, Kohli P, Kumari R, Singh P, Zakharov LN, Singh Y, Mahmud T, Lal R (2014) Modification of rifamycin polyketide backbone leads to improved drug activity against rifampicin-resistant Mycobacterium tuberculosis. J Biol Chem 289:21142–21152. doi:10.1074/jbc.M114.572636
Peano C, Damiano F, Forcata M, Pietrelli A, Palumbo C, Corti G, Siculella L, Fuligni F, Tagliazucchi GM, De Benedetto GE, Bicciato S, De Bellis G, Alifano P (2014) Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering. Metabol Eng 26:1–16. doi:10.1016/j.ymben.2014.08.001
Sharma M (2014) Actinomycetes: source, identification, and their applications. Int J Curr Microbiol Appl Sci 3:801–832. http://www.ijcmas.com/vol-3-2/Mukesh%20Sharma.pdf
Bandyopadhyay D, Das K, Sen SK (2016) Exploration of extracellular phytase production by Amycolatopsis vancoresmycina S-12 in submerged fermentation. Int J Curr Microbiol Appl Sci 5:478–487. doi:10.20546/ijcmas.2016.501.048
Kshirsagar SD, Saratale GD, Saratale RG, Govindwar SP, Oh MK (2016) An isolated Amycolatopsis sp. GDS for cellulase and xylanase production using agricultural waste biomass. J Appl Microbiol 120:112–125. doi:10.1111/jam.12988
Demain AL, Fang A (2000) The natural functions of secondary metabolites. In: Fiechter A (ed) History of modern biotechnology I. Springer, Berlin, pp 1–39
Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3 (2). Nature 417:141–147. doi:10.1038/417141a
Tang B, Zhao W, Zheng H, Zhuo Y, Zhang L, Zhao GP (2012) Complete genome sequence of Amycolatopsis mediterranei S699 based on de novo assembly via a combinatorial sequencing strategy. J Bacteriol 194:5699–5700. doi:10.1128/JB.01295-12
Verma M, Kaur J, Kumar M, Kumari K, Saxena A, Anand S, Nigam A, Ravi V, Raghuvanshi S, Khurana P, Tyagi AK, Khurana JP, Lal R (2011) Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699. J Bacteriol 193:5562–5563. doi:10.1128/JB.05819-11
Zhao W, Zhong Y, Yuan H, Wang J, Zheng H, Wang Y, Cen X, Xu F, Bai J, Han X, Lu G, Zhu Y, Shao Z, Yan H, Li C, Peng N, Zhang Z, Zhang Y, Lin W, Fan Y, Qin Z, Hu Y, Zhu B, Wang S, Ding X, Zhao GP (2010) Complete genome sequence of the Rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell Res 20:1096–1108. doi:10.1038/cr.2010.87
Nett M, Ikeda H, Moore BS (2009) Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat Prod Rep 26:1362–1384. doi:10.1039/B817069J
Lechevalier MP, Prauser H, Labeda DP, Ruan JS (1986) Two genera of nocardioform actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov. Int J Syst Bacteriol 36:29–37. doi:10.1099/00207713-36-1-29
Doroghazi JR, Metcalf WM (2013) Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes. BMC Genom 14:611. doi:10.1186/1471-2164-14-611
Chen S, Wu Q, Shen Q, Wang H (2016) Progress in understanding the genetic information and biosynthetic pathways behind Amycolatopsis antibiotics, with implications for the continued discovery of novel drugs. Chem Biol Chem 17:119–128. doi:10.1002/cbic.201500542
Xu L, Li Y, Zhu L, Zhao W, Chen D, Huang W, Yang S (2014) Characterization of plasmid pXL100 from Amycolatopsis orientalis HCCB10007 and construction of a shuttle vector. J Basic Microbiol 55:247–254. doi:10.1002/jobm.201400210
Stegmann E, Albersmeier A, Spohn M, Gert H, Weber T, Wohlleben W, Kalinowski J, Rückert C (2014) Complete genome sequence of the actinobacterium Amycolatopsis japonica MG417-CF17T (=DSM 44213T) producing (S, S)-N, N′-ethylenediaminedisuccinic acid. J Biotechnol 189:46–47. doi:10.1016/j.jbiotec.2014.08.034
Singh P, Kumari R, Mukherjee U, Saxena A, Sood U, Lal R (2014) Draft genome sequence of Rifamycin derivatives producing Amycolatopsis mediterranei strain DSM 46096/S955. Genome Announc 2:e00837-14. doi:10.1128/genomeA.00837-14
Mukherjee U, Saxena A, Kumari R, Singh P, Lal R (2014) Draft genome sequence of Amycolatopsis mediterranei DSM 40773, a tangible antibiotic producer. Genome Announc 2:e00752-14. doi:10.1128/genomeA.00752-14
Saxena A, Kumari R, Mukherjee U, Singh P, Lal R (2014) Draft genome sequence of the rifamycin producer Amycolatopsis rifamycinica DSM 46095. Genome Announc 2:e00662-14. doi:10.1128/genomeA.00662-14
Kaur N, Kumar S, Mayilraj S (2014) Genome sequencing and annotation of Amycolatopsis vancoresmycina strain DSM 44592T. Genom Data 2:16–17. doi:10.1016/j.gdata.2013.10.006
Khatri I, Subramanian S, Mayilraj S (2014) Genome sequencing and annotation of Amycolatopsis azurea DSM 43854T. Genom Data 2:44–45. doi:10.1016/j.gdata.2013.12.003
Kaur N, Kumar S, Bala M, Raghava GPS, Mayilraj S (2013) Draft genome sequence of Amycolatopsis decaplanina strain DSM 44594T. Genome Announc 1:e00138-13. doi:10.1128/genomeA.00138-13
Kwun MJ, Hong H-J (2014) Draft genome sequence of Amycolatopsis lurida NRRL 2430, producer of the glycopeptide family antibiotic ristocetin. Genome Announc 2:e01050-14. doi:10.1128/genomeA.01050-14
Jeong H, Sim YM, Kim HJ, Lee DW, Lim SK, Lee SJ (2013) Genome sequence of the vancomycin-producing Amycolatopsis orientalis subsp. orientalis strain KCTC 9412T. Genome Announc 1:e00408–e00413. doi:10.1128/genomeA.00408-13
Jeong H, Sim YM, Kim HJ, Lee YJ, Lee DW, Lim SK, Lee SJ (2013) Genome sequences of Amycolatopsis orientalis subsp. orientalis strains DSM 43388 and DSM 46075. Genome Announc 1:e00543-13. doi:10.1128/genomeA.00545-13
Davis JR, Goodwin LA, Woyke T, Teshima H, Bruce D, Detter C, Tapia R, Han S, Han J, Pitluck S, Nolan M, Mikhailova N, Land NL, Sello JK (2012) Genome sequence of Amycolatopsis sp. strain ATCC 39116, a plant biomass-degrading actinomycete. J Bacteriol 194:2396–2397. doi:10.1128/JB.00186-12
Kwun MJ, Cheng J, Yang SH, Lee D-R, Suh J-W, Hong H-J (2014) Draft genome sequence of ristocetin-producing strain Amycolatopsis sp. strain MJM2582 isolated in South Korea. Genome Announc 2:e01091-14. doi:10.1128/genomeA.01091-14
August PR, Tang L, Yoon YJ, Ning S, Müller R, Yu TW, Taylor M, Hoffmann D, Kim CG, Zhang X, Hutchinson CR, Floss HG (1998) Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem Biol 5:69–79. doi:10.1016/S1074-5521(98)90141-7
Shao ZH, Ren SX, Liu XQ, Xu J, Zhao GP, Wang J (2015) A preliminary study of the mechanism of nitrate-stimulated remarkable increase of rifamycin production in Amycolatopsis mediterranei U32 by RNA-seq. Microb Cell Fact 14:75. doi:10.1186/s12934-015-0264-y
Shao Z, Gao J, Ding X, Wang J, Chiao J, Zhao G (2011) Identification and functional analysis of a nitrate assimilation operon nasACKBDEF from Amycolatopsis mediterranei U32. Arch Microbiol 193:463–477. doi:10.1007/s00203-011-0690-0
Admiraal SJ, Walsh CT, Khosla C (2001) The loading module of rifamycin synthetase is an adenylation–thiolation didomain with substrate tolerance for substituted benzoates. Biochemistry 40:6116–6123. doi:10.1021/bi010080z
Xu J, Wan E, Kim CJ, Floss HG, Mahmud T (2005) Identification of tailoring genes involved in the modification of the polyketide backbone of rifamycin B by Amycolatopsis mediterranei S699. Microbiology 151:2515–2528. doi:10.1099/mic.0.28138-0
Admiraal SJ, Khosla C, Walsh CT (2003) A Switch for the transfer of substrate between nonribosomal peptide and polyketide modules of the rifamycin synthetase assembly line. J Am Chem Soc 125:13664–13665. doi:10.1021/ja0379060
Floss HG, Yu TW (2005) Rifamycin-mode of action, resistance, and biosynthesis. Chem Rev 105:621–632. doi:10.1021/cr030112j
Lal R, Khanna M, Kaur H, Srivastava N, Tripathi KK, Lal S (1995) Rifamycins: strain improvement program. Crit Rev Microbiol 21:19–30. doi:10.3109/10408419509113532
Udwadia ZF (2012) MDR, XDR, TDR tuberculosis: ominous progression. Thorax 67:286–288. doi:10.1136/thoraxjnl-2012-201663
Xu J, Mahmud T, Floss HG (2003) Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699. Arch Biochem Biophys 411:277–288. doi:10.1016/S0003-9861(03)00004-3
Baranasic D, Gacesa R, Starcevic A, Zucko J, Blažič M, Horvat M, Gjuračić K, Fujs Š, Hranueli D, Kosec G, Cullum J (2013) Draft genome sequence of Streptomyces rapamycinicus strain NRRL 5491, the producer of the immunosuppressant rapamycin. Genome Announc 1:e00581-13. doi:10.1128/genomeA.00581-13
Goodfellow M, Brown AB, Cai JP, Chun JS, Collins MD (1997) Amycolatopsis japonicum sp. nov, an actinomycete producing (S, S)-N, N′-ethylenediaminedisuccinic acid. Syst Appl Microbiol 20:78–84. doi:10.1016/S0723-2020(97)80051-3
Schäberle TF, Vollmer W, Frasch HJ, Hüttel S, Kulik A, Röttgen M, von Thaler AK, Wohlleben W, Stegmann E (2011) Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycina. Antimicrob Agents Chemother 55:4283–4289. doi:10.1128/AAC.01372-10
Everest GJ, Meyers PR (2011) Evaluation of the antibiotic biosynthetic potential of the genus Amycolatopsis and description of Amycolatopsis circi sp. nov., Amycolatopsis equina sp. nov. and Amycolatopsis hippodromi sp. nov. J Appl Microbiol 111:300–311. doi:10.1111/j.1365-2672.2011.05058.x
Banskota AH, Mcalpine JB, Sørensen D, Ibrahim A, Aouidate M, Piraee M, Alarco AM, Farnet CM, Zazopoulos E (2006) Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class. J Antibiot (Tokyo) 59:533–542. doi:10.1038/ja.2006.74
Spohn M, Kirchner N, Kulik A, Jochim A, Wolf F, Muenzer P, Borst O, Gross H, Wohlleben W, Stegmann E (2014) Overproduction of ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum MG417-CF17. Antimicrob Agents Chemother 58:6185–6196. doi:10.1128/AAC.03512-14
Dijkhuizen L (1996) Metabolic regulation in the actinomycete Amycolatopsis methanolica, a facultative methylotroph employing the rump cycle for formaldehyde assimilation. In: Microbial growth on C1 compounds. Springer, pp 9–15. doi: 10.1007/978-94-009-0213-8_3
Seyedsayamdost MR, Traxler MF, Zheng SL, Kolter R, Clardy J (2011) Structure and biosynthesis of amychelin, an unusual mixed-ligand siderophore from Amycolatopsis sp. AA4. J Am Chem Soc 133:11434–11437. doi:10.1021/ja203577e
Xie F, Dai S, Shen J, Ren B, Huang P, Wang Q, Liu X, Zhang B, Dai H, Zhang L (2015) A new salicylate synthase AmS is identified for siderophores biosynthesis in Amycolatopsis methanolica 239T. Appl Microbiol Biotechnol 99:1–11. doi:10.1007/s00253-014-6370-7
Harrison AJ, Yu M, Gårdenborg T, Middleditch M, Ramsay RJ, Baker EN, Lott JS (2006) The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase. J Bacteriol 188:6081–6091. doi:10.1128/JB.00338-06
Kerbarh O, Ciulli A, Howard NI, Abell C (2005) Salicylate biosynthesis: overexpression, purification, and characterization of Irp9, a bifunctional salicylate synthase from Yersinia enterocolitica. J Bacteriol 187:5061–5066. doi:10.1128/JB.187.15.5061-5066.2005
Berdnikova TF, Shashkov AS, Katrukha GS, Lapchinskaya OA, Yurkevich NV, Grachev AA, Nifant’ev NE (2009) The structure of antibiotic eremomycin B. Russ J Bioorg Chem 35:497–503. doi:10.1134/S1068162009040128
Tsuji K, Kobayashi M, Kamigauchi T, Yoshimura Y, Terui Y (1988) New glycopeptide antibiotics. I. The structures of orienticins. J Antibiot (Tokyo) 41:819–822. doi:10.7164/antibiotics.41.819
Acknowledgments
This research work was supported by grants from the Department of Biotechnology (DBT), Government of India, National Bureau of Agriculturally Important Microorganisms (NBAIM) AMASS/2006-07/NBAIM/CIR and All India Network Project Soil Biodiversity-Biofertilizer (ICAR). R.K. and P.S. gratefully acknowledge UGC, for providing research fellowships.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumari, R., Singh, P. & Lal, R. Genetics and Genomics of the Genus Amycolatopsis . Indian J Microbiol 56, 233–246 (2016). https://doi.org/10.1007/s12088-016-0590-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-016-0590-8